Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series-Reference-Cited by-同舟云学术

Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series

Published:2020-02-29 Issue:1 Volume:18 Page:159-163
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Kamei Hiroyuki¹²^ORCID,Yamada Hanae²^ORCID,Hatano Masakazu¹³²^ORCID,Hanya Manako²^ORCID,Yamada Shigeki³^ORCID,Iwata Nakao¹^ORCID

Affiliation:

1. Departments of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan

2. Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy, Meijo University, Nagoya, Japan

3. Departments of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Japan

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

http://pdf.medrang.co.kr/CPN2/2020/018/cpn018-01-18.pdf

Reference13 articles.

1. Identifying Clinically Questionable Psychotropic Prescribing Practices for Medicaid Recipients in New York State

2. Correll CU, Kane JM. Is there a rationale for antipsychotic polypharmacy in schizophrenia?. Schizophrene Stoerungen-State of the Art III, Fleischhacker WW, Hummer M. Innsbruck: Verlag Integrative Psychiatrie; 2004:95-112.

3. Effectiveness of Switching From Antipsychotic Polypharmacy to Monotherapy

4. Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia

5. Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypharmacy Management of Antipsychotics in Patients with Schizophrenia;Medicina;2022-11-03

2. Machine-Learning for Prescription Patterns: Random Forest in the Prediction of Dose and Number of Antipsychotics Prescribed to People with Schizophrenia;Clinical Psychopharmacology and Neuroscience;2022-08-31

3. Review: Influence of the CYP450 Genetic Variation on the Treatment of Psychotic Disorders;Journal of Clinical Medicine;2021-09-21

4. Patient Factors Influencing Outpatient Retention in Patients with Affective and Anxiety Disorders: A Retrospective Study;Clinical Psychopharmacology and Neuroscience;2021-08-31

5. Application of a Pharmacogenetics-Based Precision Medicine Model (5SPM) to Psychotic Patients That Presented Poor Response to Neuroleptic Therapy;Journal of Personalized Medicine;2020-12-18